Home Communities Breast Imaging Demand for adjunctive imaging for breast cancer results in 'dramatic' camera sales surge at Dilon

Demand for adjunctive imaging for breast cancer results in 'dramatic' camera sales surge at Dilon

Communities
Dilon Technologies ended 2006 with a strong 4th quarter, the company has announced. The US medical device manufacturer of a high-resolution, small field-of-view gamma cameras tripled the prior year's camera orders. Dilon Technologies ended 2006 with a strong 4th quarter, the company has announced. The US medical device manufacturer of a high-resolution, small field-of-view gamma cameras tripled the prior year's camera orders. The company is also making significant gains in Europe, Canada and Korea.

Breast-specific gamma imaging (BSGI) has a growing reputation for a being a critically valuable diagnostic tool, or 'next-step' measure, when mammography is inconclusive.

In using BSGI with the Dilon 6800, radiologist Ted Fogarty, M.D. (Medcenter One Hospital of Bismarck, ND) says he has experienced "remarkable diagnostic results". "In our practice, we serendipitously integrated this BSGI unit at the start of 2006. Our practice has averaged around 50 cancer diagnoses per year in 2003, 2004, and 2005. With the rollout of the new innovative advance in 2006 we found 93 cancers." Dr Fogarty is Chairman of Radiology at the University of North Dakota School of Medicine.

Dr. Fogarty underscored the Dilon camera's importance by also commenting, "Medcenter One purchased the Dilon 6800 Gamma Camera to effectively deal with the limitations in mammography. Mammograms can be so hindered by dense breast tissue that this condition can significantly decrease the effectiveness of finding cancer with mammography alone. BSGI is an ideal diagnostic complement to mammography. Paired, these two imaging modalities significantly increase the likelihood of catching cancers in their earliest and most treatable stages."

Lon Slane, President of Dilon Technologies, attributes Dilon's ever- increasing success to "the growing appreciation of BSGI among notable physicians from around the country and extensive medical educational and promotional efforts supported by capital infusion in Spring 2006." Mr. Slane added, "The thousands of success stories of the Dilon system provided critical information for improved diagnosis and case management for doctors and their patients.
Trackback(0)
Comments (0)Add Comment

Write comment
smaller | bigger

busy
 

Related Articles